Clinical Trials Logo

Clinical Trial Summary

This research project aims to investigate the everyday relevance of reactive hypoglycemia (hypoglycemia after a glucose load) in the oral glucose tolerance test (OGTT). Therefore, blood glucose profiles in everyday life will be examined using continuous glucose measurement (Free Style Libre PRO IQ system) over a period of 14 days in affected persons.


Clinical Trial Description

The aim of this analysis is to examine people who underwent an OGTT due to various endocrinological and metabolic issues and developed reactive hypoglycemia, defined as a drop in blood glucose <70mg/dl during the course of the test. During OGTT routine laboratory testing will be performed as part of routine clinical practice. In order to investigate the occurrence and perception of hypoglycaemia in the everyday lives of those affected, their blood glucose profiles will be recorded and evaluated over a period of 14 days. In addition, the perception of (suspected) hypoglycemia and counteraction will be documented. Anthropometric data will be recorded and a bioelectrical impedance analysis performed to check a correlation with the body composition. Subjects will be recruited via the endocrinology outpatient clinic as part of medical care. To date, very little CGM data are available on the frequency and extent of reactive hypoglycemia in the everyday lives of people without diabetes mellitus. Therefore, 20 subjects with hypoglycemia in the OGTT will be included in this exploratory pilot study for hypothesis generation in order to investigate the occurrence and perception of hypoglycemia in everyday life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06182527
Study type Interventional
Source University of Ulm
Contact Julia Hummel, PhD
Phone +4973150044744
Email julia.hummel@uniklinik-ulm.de
Status Recruiting
Phase N/A
Start date December 27, 2023
Completion date December 2024

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03514576 - Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery Phase 4
Completed NCT03353415 - Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery N/A
Completed NCT05057819 - Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Phase 4
Terminated NCT04452396 - CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia N/A